-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Gfc8fEjfH0F43kv9ktFtx473HPyHvKNVQpfIE++AbscN2Yn2UEBpCgaYi5ntUB8s
 j3p0nFeQ/c4fm4wYhdaCDA==

<SEC-DOCUMENT>0001171520-08-000293.txt : 20080515
<SEC-HEADER>0001171520-08-000293.hdr.sgml : 20080515
<ACCEPTANCE-DATETIME>20080515142342
ACCESSION NUMBER:		0001171520-08-000293
CONFORMED SUBMISSION TYPE:	NT 10-Q
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080331
FILED AS OF DATE:		20080515
DATE AS OF CHANGE:		20080515
EFFECTIVENESS DATE:		20080515

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TAPIMMUNE INC
		CENTRAL INDEX KEY:			0001094038
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				880277072
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		NT 10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-27239
		FILM NUMBER:		08836291

	BUSINESS ADDRESS:	
		STREET 1:		UNIT 2 - 3590 WEST 41ST AVENUE
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6N 3E6
		BUSINESS PHONE:		604-264-8274

	MAIL ADDRESS:	
		STREET 1:		UNIT 2 - 3590 WEST 41ST AVENUE
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6N 3E6

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GENEMAX CORP
		DATE OF NAME CHANGE:	20020718

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EDUVERSE COM
		DATE OF NAME CHANGE:	19990827
</SEC-HEADER>
<DOCUMENT>
<TYPE>NT 10-Q
<SEQUENCE>1
<FILENAME>form12b25-1210807223.htm
<DESCRIPTION>TAPIMMUNE, INC.
<TEXT>
<html>
<head>
    <title>FORM 12b-25 Notification of Late Filing</title>
</head>
<!-- Production by EDGARfilingagent.com -->
<body style="font-size: 15px; text-align: justify; font-family: Times New Roman, Times, serif; margin: 0px; padding: 30px;">
    <div id="doc" style="width: 810px; position: relative; left: 3%; border: 1px solid black;">
        <div id="docIn" style="margin: 30px;">
        <div id="header">
            <div style="float: right;">
                <div class="rightBox" style="text-align: left; margin: 2px; border: 1px solid #000000; width: 190px; padding: 3px; font-family: Arial, sans-serif; font-size: 13px;">
                    <div class="insideRightBox" style="padding-left: 3px; padding-right: 3px; margin-left: -3px; margin-right: -3px; position: relative; border-bottom: 1px solid #000000;font-family: Times New Roman, Times, serif; height: 17px;    text-align: center;">OMB APPROVAL</div>
                    OMB Number:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3235-0058<br />
                    Expires:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;April 30, 2009<br />
                    Estimated average burden<br />hours per response. . . . . 2.50
                </div>
                <div class="rightBox" style="font-family: Courier New, Courier, monospace; margin: 2px;    border: 1px solid #000000; width: 190px; padding: 3px; font-size: 13px;    text-align: center;">
                    SEC FILE NUMBER
                    <br />
                    <b>0-27239 </b>
                </div>
                <div class="rightBox" style="font-family: Courier New, Courier, monospace; margin: 2px;    border: 1px solid #000000; width: 190px; padding: 3px; font-size: 13px;    text-align: center;">
                    CUSIP NUMBER
                    <br />
                    <b>876033 101</b>
                </div>
            </div>
            <div>
                <center style="font-size: 15px;">
                    <b>UNITED STATES <br /> SECURITIES AND EXCHANGE COMMISSION <br />
                    Washington, D.C. 20549
                    <p /><br />
                    <font style="font-size: 20px; font-family: Arial, sans-serif;">FORM 12b-25</font>
                    <p /><br />
                    NOTIFICATION OF LATE FILING</b>
                </center>
            </div>
        </div>
        <p style="clear: both;" /><br />
        <div id="form">
            <table border="0" cellspacing="0" cellpadding="0">
                <tr>
                    <td valign="top" width="100">
                        <i>(Check one):</i>
                    </td>
                    <td>
                        <font face="wingdings">&#111;</font>Form 10-K&nbsp;&nbsp;
                        <font face="wingdings">&#111;</font>Form 20-F&nbsp;&nbsp;
                        <font face="wingdings">&#111;</font>Form 11-K&nbsp;&nbsp;
                        <font face="wingdings">&#253;</font>Form 10-Q&nbsp;&nbsp;
                        <font face="wingdings">&#111;</font>Form 10-D&nbsp;&nbsp;
                        <font face="wingdings">&#111;</font>Form N-SAR
                    </td>
                </tr>
                <tr>
                    <td>&nbsp;</td>
                    <td>
                        &nbsp;&nbsp;<font face="wingdings">&#111;</font>Form N-CSR
                        <br />
                        <div style="margin-left: 16px;">
                            <div style="border-bottom: 1px solid #000000;">For Period Ended: <b>March 31 2008</b></div>
                            <font face="wingdings">&#111;</font>&nbsp;&nbsp;Transition Report on Form 10-K<br />
                            <font face="wingdings">&#111;</font>&nbsp;&nbsp;Transition Report on Form 20-F<br />
                            <font face="wingdings">&#111;</font>&nbsp;&nbsp;Transition Report on Form 11-K<br />
                            <font face="wingdings">&#111;</font>&nbsp;&nbsp;Transition Report on Form 10-Q<br />
                            <font face="wingdings">&#111;</font>&nbsp;&nbsp;Transition Report on Form N-SAR<br />
                            <div style="border-bottom: 1px solid #000000;">For the Transition Period Ended: <b></b></div>
                        </div>
                    </td>
                </tr>
            </table>
        </div>
        <br />
        <div id="form2" style="border: 1px solid black; font-size: 14px;">
            <div id="form2-1" style="text-align: center; padding: 5px;">
                <i>Read Instruction (on back page) Before Preparing Form. Please Print or Type.</i><br />
                <b>Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.</b>
            </div>
        </div>
        <br />
        <div id="part1">
            If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:<br />
            <center style="width: 100%; border-bottom: 1px solid #000000;"><br /><b></b></center><p />

            <b>PART 1 &mdash; REGISTRANT INFORMATION</b>
            <p />
            <div style="border-bottom: 1px solid #000000;"><b>TapImmune Inc</b></div>
            Full Name of Registrant<p />
            <div style="border-bottom: 1px solid #000000;"><b></b></div>
            Former Name if Applicable<p />
            <div style="border-bottom: 1px solid #000000;"><b>202-3590 West 41st Ave</b></div>
            Address of Principal Executive Officer <i>(Street and Number)</i><p />
            <div style="border-bottom: 1px solid #000000;"><b>Vancouver, BC V6N3E6</b></div>
            City, State and Zip Code<p />
        </div>
        <br />
        <div id="part2">
            <b>PART 2 &mdash; RULES 12b-25(b) AND (c)</b>
            <p />
            If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief
            pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
            <table>
                <tr>
                    <td valign="center" width="75" style="border-right: 1px solid #000000;">
                        <p align="right">
                            <font face="wingdings" style="margin-right: 10px;">&#253;</font>
                        </p>
                    </td>
                    <td>
                        <ol style="list-style-type: lower-alpha;">
                            <li>The reason described in reasonable detail in Part III of this form could not be
                                    eliminated without unreasonable effort or expense.
                            </li>
                            <li>The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F,
                                    Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the
                                    fifteenth calendar day following the prescribed due date; or the subject quarterly report
                                    or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion
                                    thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
                            </li>
                            <li>The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
                            </li>
                        </ol>
                    </td>
                </tr>
            </table>
        </div>
        <br />
        <div id="part3">
            <b>PART III &mdash; NARRATIVE</b>
            <p />
            State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or
            portion thereof, could not be filed within the prescribed time period.<p />
            <div style="border-top: 2px solid #75736E; border-left: 2px solid #75736E; border-bottom: 2px solid #F2F0EE; border-right: 2px solid #F2F0EE; overflow: auto; height: 150px;"><b>
Management was unable to obtain certain of the business information necessary to
complete the preparation of the Company's Form 10-Q for the period ended March
31, 2008 and the review of the report by the Company's auditors in time for
filing. Such information is required in order to prepare a complete filing. As a
result of this delay the Company is unable to file its interim report on Form
10-Q within the prescribed time period without unreasonable effort or expense.
The Company expects to file within the extension period.</b></div>
        </div>
        <br />
        <div id="part4">
            <b>PART IV &mdash; OTHER INFORMATION</b>
            <p />
            <ol>
                <li>Name and telephone number of person to contact in regard to this notification.<br />
                        <table>
                            <tr>
                                <td colspan="3">

                                </td>
                            </tr>
                            <tr>
                                <td style="text-align: center; padding-right: 15px;">
                                    <div style="border-bottom: 1px solid #000000; width: 300px; text-align: center;"><b>Denis Corin</b></div>
                                    (Name)
                                </td>
                                <td style="text-align: center; padding-right: 15px;">
                                    <div style="border-bottom: 1px solid #000000; width: 145px; text-align: center;"><b>604 </b></div>
                                    (Area Code)
                                </td>
                                <td style="text-align: center;">
                                    <div style="border-bottom: 1px solid #000000; width: 235px; text-align: center;"><b>264 8274</b></div>
                                    (Telephone Number)
                                </td>
                            </tr>
                            <tr>
                            </tr>
                        </table>
                </li>
                <li>
                        Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934
                        or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter
                        period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
                        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                        Yes <font face="wingdings">&#253;</font>
                        &nbsp;&nbsp;&nbsp;
                        No <font face="wingdings">&#111;</font>
                        <br />
                        <div style="border-bottom: 1px solid #000000; text-align: center;"><b></b></div>
                </li>
                <li>
                        Is it anticipated that any significant change in results of operations from the corresponding period for
                        the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
                        &nbsp;&nbsp;
                        Yes <font face="wingdings">&#111;</font>
                        &nbsp;&nbsp;&nbsp;
                        No <font face="wingdings">&#253;</font>
                        <p />
                        If so, attach an explanation of the anticipated change, both narratively and quantitatively, and,
                        if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
                        <br />
                        <div style="border-top: 2px solid #75736E; border-left: 2px solid #75736E; border-bottom: 2px solid #F2F0EE; border-right: 2px solid #F2F0EE; overflow: auto; height: 50px;"><b></b></div>
                </li>
            </ol>
        </div>
        <hr color="#000000" />
        <br />
        <div id="close">
            <center>
                <div style="border-bottom: 1px solid #000000; width: 435px; text-align: center;"><b>TapImmune Inc</b></div>
                (Name of Registrant as Specified in Charter)
            </center><br />
            has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.<p />

            <table>
                <tr>
                    <td>Date&nbsp;</td>
                    <td><div style="border-bottom: 1px solid #000000; width: 300px; text-align: center;"><b>May 15 2008</b></div></td>
                    <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By</td>
                    <td><div style="border-bottom: 1px solid #000000; width: 300px; text-align: center;"><b>Denis Corin - CEO TapImmune Inc.</b></div></td>
                </tr>
            </table>
            <p />

            INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative.
            The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed
            on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the
            representative's authority to sign on behalf of the registrant shall be filed with the form.
        </div>
        <div id="instruction">
            <div style="text-align: center; border: 1px ridge #222228">
                <center style="font-size: 18px;"><b>ATTENTION</b></center>
                <b>Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).</b>
            </div>
            <p />
            <center>
                <b>GENERAL INSTRUCTIONS</b>
            </center>
            <ol>
                <li>This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General Rules and Regulations under the Securities Exchange Act of 1934.</li>
                <li>One signed original and four conformed copies of this form and amendments thereto must be completed and filed with
                    the Securities and Exchange Commission, Washington D.C. 20549, in accordance with Rule 0-3 of the General Rules
                    and Regulations under the Act. The information contained in or filed with the form will be made a matter
                    of public record in the Commission files.</li>
                <li>A manually signed copy of the form and amendments thereto shall be filed with each national securities exchange on
                    which any class of securities of the registrant is registered.</li>
                <li>Amendments to the notifications must also be filed on Form 12b-25 but need not restate information that has been
                    correctly furnished. The form shall be clearly identified as an amended notification.</li>
                <li><i>Electronic Filers:</i> This form shall not be used by electronic filers unable to timely file a report solely due to
                    electronic difficulties. Filers unable to submit reports within the time period prescribed due to difficulties in
                    electronic filing should comply with either Rule 201 or Rule 202 of Regulation S-T (&sect;232.201 or &sect;232.202 of this chapter)
                    or apply for an adjustment in filing pursuant to Rule 13(b) of Regulation S-T (&sect;232.13(b) of this chapter).
            </ol>
        </div>
        <p align="right">
        </p>
        </div>
    </div>
</body>
</html>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
